How to cite item

Front-line erlotinib in unselected patients with advanced NSCLC and poor performance status - the TOPICAL study

   
@article{TLCR628,
	author = {Niki Karachaliou and Jia Wei and Ana Daniela Marques and Rafael Rosell},
	title = {Front-line erlotinib in unselected patients with advanced NSCLC and poor performance status - the TOPICAL study},
	journal = {Translational Lung Cancer Research},
	volume = {2},
	number = {1},
	year = {2012},
	keywords = {},
	abstract = {Lung cancer has long been recognized as an extremely heterogeneous disease since its development, in terms of clinical characterizations, prognosis, response and tolerance to treatment, is unique in every patient. Eastern Cooperative Oncology Group performance status (ECOG PS) is the most important predictor of outcome in advanced non-small-cell lung cancer (NSCLC). Patients with PS ≥2 tend to tolerate treatment poorly and have significantly inferior survival compared with patients with PS 0 to 1 (1).},
	issn = {2226-4477},	url = {https://tlcr.amegroups.org/article/view/628}
}